Acute Lung Injury Market: Industry Analysis, Drugs, Key Companies by DelveInsight | Altor BioScience, Apeiron Biologics, Theravance Biopharma, Viela Bio, ReAlta Life Sciences, Cantex Pharmaceuticals, Asklepion Pharmaceuticals and Others
Acute Lung Injury is a life-threatening condition caused by severe acute hypoxemic respiratory failure. It is a key source of mortality and morbidity in critically ill patients without any evidence of hydrostatic pulmonary edema. Symptoms observed in acute lung injury include severe shortness of breath, low blood pressure, confusion, and extreme tiredness. This type of injury has a substantial impact on public health, with a high incidence across the world and it requires administration of a fast and goal-oriented therapy to suppress further lung damage.
DelveInsight's "Acute
Lung Injury Market Insights, Epidemiology, and Market
Forecast-2030" report delivers an in-depth understanding of the
Acute Lung Injury, historical and forecasted epidemiology as well as the Acute
Lung Injury market trends in the United States, EU5 (Germany, Spain, Italy,
France, and United Kingdom) and Japan.
Some Facts of Acute
Lung Injury Market
Report:
·
The
rising prevalence of acute lung injuries is expected to boost market growth
over the forecast period.
·
For
instance, according to the National Heart, Lung, and Blood Institute, 79
people per 100,000 population per year developed acute lung injury (ALI),
and 59 of these met the criteria for the more severe form of acute respiratory
distress syndrome. The death rate of acute lung injury patients was around 38.5
%.
·
Using
the US census and assuming the same frequency throughout the country, 190,600
people per year develop ALI, and 74,500 dies off, or with, the disease
in the US. Thus, the rising prevalence of acute lung injuries is driving the
market.
Request for Free Sample Report: https://www.delveinsight.com/sample-request/acute-lung-injury-market
View Report: https://www.delveinsight.com/report-store/acute-lung-injury-market
Some of Acute
Lung Injury Companies
are:
·
Altor BioScience
·
Apeiron Biologics
·
Theravance Biopharma
·
Viela Bio
·
ReAlta Life Sciences
·
Cantex Pharmaceuticals
·
Asklepion Pharmaceuticals
·
Stemedica Cell Technologies
·
Forschung und Entwicklung
·
FirstString Research
·
Histocell S.L.
·
GlaxoSmithKline
·
S-Evans Biosciences
·
CompleGen
·
Commence Bio
·
Windtree Therapeutics
·
And Many Others
Request for Free Sample Report: https://www.delveinsight.com/sample-request/acute-lung-injury-market
View Report: https://www.delveinsight.com/report-store/acute-lung-injury-market
Scope of Acute
Lung Injury Market:
- The
report covers the descriptive overview of Acute Lung Injury, explaining
its causes, signs and symptoms, pathophysiology, diagnosis and currently
available therapies
- Comprehensive
insight has been provided into the Acute
Lung Injury epidemiology and treatment in the 7MM
- Additionally,
an all-inclusive account of both the current and emerging therapies for
Acute Lung Injury are provided, along with the assessment of new therapies,
which will have an impact on the current treatment landscape
- A
detailed review of Acute Lung Injury market; historical and forecasted is
included in the report, covering drug outreach in the 7MM
- The
report provides an edge while developing business strategies, by
understanding trends shaping and driving the global Acute Lung Injury
market
Some of Acute
Lung Injury Therapies
are:
·
APN01
·
TD-0903
·
VIB7734
·
RLS 0071
·
Dociparstat sodium
·
L-citrulline
·
And Many Others
Request for Free Sample Report: https://www.delveinsight.com/sample-request/acute-lung-injury-market
View Report: https://www.delveinsight.com/report-store/acute-lung-injury-market
Key Acute
Lung Injury Market
Questions:
- What
was the Acute Lung Injury market share (%) distribution in 2017 and how it
would look like in 2030?
- What
would be the Acute Lung Injury total market size as well as market size by
therapies across the 7MM during the forecast period (2017-2030)?
- What
are the key findings pertaining to the market across 7MM and which country
will have the largest Acute Lung Injury market size during the forecast
period (2017-2030)?
- At
what CAGR, the Acute Lung Injury market is expected to grow in 7MM during the
forecast period (2017-2030)?
- What
would be the Acute Lung Injury market outlook across the 7MM during the
forecast period (2017-2030)?
- What
would be the Acute Lung Injury market growth till 2030, and what will be
the resultant market Size in the year 2030?
- How
would the market drivers, barriers and future opportunities affect the
market dynamics and subsequent analysis of the associated trends?
Request for Free Sample Report: https://www.delveinsight.com/sample-request/acute-lung-injury-market
View Report: https://www.delveinsight.com/report-store/acute-lung-injury-market
Table of Contents:
1. Key Insights
2. Executive Summary
of Acute Lung Injury
3. Competitive
Intelligence Analysis for Acute Lung Injury
4. Acute Lung
Injury: Market Overview at a Glance
5. Acute Lung
Injury: Disease Background and Overview
6. Patient Journey
7. Acute Lung Injury
Epidemiology and Patient Population
8. Treatment
Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of
Acute Lung Injury Treatment
11. Marketed
Products
List to be continued
in report
12. Emerging
Therapies
List to be continued
in report
13. Acute Lung
Injury: Seven Major Market Analysis
14. Attribute
analysis
15. 7MM: Market
Outlook
16. Access and
Reimbursement Overview of Acute Lung Injury
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight
Capabilities
22. Disclaimer
23. About
DelveInsight
Discuss the evolving trends of market landscape @ Acute Lung Injury Market Forecast
Get in touch with our Business executive for Rich and Deep Market
Assessment and Consulting Solutions
Other Links:
·
Electrophysiology
Devices Market
·
Growth
Hormone Deficiency Market
·
Interventional
Neuroradiology Market
·
Intracranial
Pressure Monitoring Devices Market
·
Foot
and Ankle Devices Market
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused
exclusively on life sciences. It supports pharma companies by providing
end-to-end comprehensive solutions to improve their performance.
Contact us
Ankit Nigam
info@delveinsight.com
+91-9650213330
Connect With Us at:
Request for Free Sample Report: https://www.delveinsight.com/sample-request/acute-lung-injury-market
Comments
Post a Comment